<DOC>
	<DOCNO>NCT01124500</DOCNO>
	<brief_summary>The purpose study compare effect , good and/or bad , Methylphenidate patch placebo patch ( patch contain medicine ) patient fatigue caused cancer cancer treatment . The Methylphenidate patch contain medication know increase alertness wakefulness . Oral methylphenidate use past treat cancer relate fatigue often use treat unusual sleepiness . But first time patch form offer try treat cancer fatigue patient always swallow tablet .</brief_summary>
	<brief_title>Transdermal Methylphenidate Cancer-Related Fatigue</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Diagnosis head neck cancer underwent combine modality treatment curative intent Has undergone cancer treatment last 4 week Is 21 year age old Fatigue scale score 4 high Is able understand English , write verbal communication In judgment consent professional , able provide inform consent Physically able present followup appointment outpatient Radiation Oncology Pain &amp; Palliative Care clinic Probable life expectancy 6 month Pulmonary cardiovascular failure , seizure disorder , sleep disorder , mental impairment , psychiatric disorder , pregnancy Has know sensitivity allergy methylphenidate Receiving concurrent treatment psychostimulant Hospitalized patient Evidence impair hepatic renal function ( hyperbilirubinemia , great two fold elevation transaminase ; &gt; 40mg/dl BUN &gt; 1.5mg/dl Cr ) Anemia ( hemoglobin &lt; 10mg/dl )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>methylphenidate</keyword>
	<keyword>transdermal patch</keyword>
	<keyword>placebo</keyword>
	<keyword>fatigue</keyword>
	<keyword>10-020</keyword>
</DOC>